1. Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma
   Min Kyu Kang et al, 2018, Medicine CrossRef
2. Efficacy and optimal treatment sequence of Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
   Yasunari Hiramine et al, 2013, Kanzo CrossRef
3. New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
   Hyun Young Woo et al, 2015, Clinical and Molecular Hepatology CrossRef
4. Pseudo-capsulated Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy Versus Transcatheter Arterial Chemoembolization
   Chao An et al, 2024, Academic Radiology CrossRef
5. Efficacy of hepatic arterial infusion chemotherapy and its combination strategies for advanced hepatocellular carcinoma: A network meta-analysis
   Shun-An Zhou et al, 2024, World Journal of Gastrointestinal Oncology CrossRef
6. Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis
   Bo-wen Zhuang et al, 2019, Japanese Journal of Clinical Oncology CrossRef
7. Current management of hepatocellular carcinoma: An Eastern perspective
   Hyung Joon Yim, 2015, World Journal of Gastroenterology CrossRef
8. Expression of human leukocyte antigen-G and acute rejection in patients following liver transplantation
   WEI-YU HU et al, 2014, Experimental and Therapeutic Medicine CrossRef
9. Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score‐based weighting
   Masaaki Kondo et al, 2015, Journal of Digestive Diseases CrossRef
10. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside
    Reina Sasaki et al, 2019, International Journal of Molecular Sciences CrossRef
11. Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index
    Takamasa Ohki et al, 2017, Advances in Therapy CrossRef
12. The Role of Hepatic Arterial Infusion Chemotherapy in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Shengzhou Li et al, 2021, Chemotherapy CrossRef
13. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Jong Hwan Choi et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef
14. Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method
    Kotaro Fukubayashi et al, 2015, Cancer Medicine CrossRef
15. Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case series
    TOMOYUKI NEMOTO et al, 2014, Molecular and Clinical Oncology CrossRef
16. A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Do Seon Song et al, 2015, Journal of Gastroenterology CrossRef
17. Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin
    Sun Hong Yoo et al, 2020, Cancer Control CrossRef